209 related articles for article (PubMed ID: 22364325)
1. Lurasidone for schizophrenia: what's different?
Kantrowitz JT; Citrome L
Expert Rev Neurother; 2012 Mar; 12(3):265-73. PubMed ID: 22364325
[TBL] [Abstract][Full Text] [Related]
2. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
[TBL] [Abstract][Full Text] [Related]
3. Lurasidone in schizophrenia: new information about dosage and place in therapy.
Citrome L
Adv Ther; 2012 Oct; 29(10):815-25. PubMed ID: 23001538
[TBL] [Abstract][Full Text] [Related]
4. Lurasidone (latuda®): an atypical antipsychotic.
Nolan SF; Roman MW
Issues Ment Health Nurs; 2012 May; 33(5):342-3. PubMed ID: 22545643
[TBL] [Abstract][Full Text] [Related]
5. Lurasidone: an atypical antipsychotic for schizophrenia.
Risbood V; Lee JR; Roche-Desilets J; Fuller MA
Ann Pharmacother; 2012; 46(7-8):1033-46. PubMed ID: 22828971
[TBL] [Abstract][Full Text] [Related]
6. Lurasidone: a new drug in development for schizophrenia.
Meyer JM; Loebel AD; Schweizer E
Expert Opin Investig Drugs; 2009 Nov; 18(11):1715-26. PubMed ID: 19780705
[TBL] [Abstract][Full Text] [Related]
7. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
8. Lurasidone: a new treatment option for schizophrenia.
Owen RT
Drugs Today (Barc); 2011 Nov; 47(11):807-16. PubMed ID: 22146224
[TBL] [Abstract][Full Text] [Related]
9. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
Nasrallah HA; Silva R; Phillips D; Cucchiaro J; Hsu J; Xu J; Loebel A
J Psychiatr Res; 2013 May; 47(5):670-7. PubMed ID: 23421963
[TBL] [Abstract][Full Text] [Related]
10. Lurasidone: a clinical overview.
Kane JM
J Clin Psychiatry; 2011; 72 Suppl 1():24-8. PubMed ID: 22217440
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.
Citrome L; Cucchiaro J; Sarma K; Phillips D; Silva R; Tsuchiya S; Loebel A
Int Clin Psychopharmacol; 2012 May; 27(3):165-76. PubMed ID: 22395527
[TBL] [Abstract][Full Text] [Related]
12. [Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].
Samalin L; Ben Gharbia M; Garnier M; Llorca PM
Encephale; 2014 Dec; 40(6):507-17. PubMed ID: 25453735
[TBL] [Abstract][Full Text] [Related]
13. A review of published evidence reporting on the efficacy and pharmacology of lurasidone.
McIntyre RS; Cha DS; Alsuwaidan M; McIntosh D; Powell AM; Jerrell JM
Expert Opin Pharmacother; 2012 Aug; 13(11):1653-9. PubMed ID: 22559286
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
McEvoy JP; Citrome L; Hernandez D; Cucchiaro J; Hsu J; Pikalov A; Loebel A
J Clin Psychiatry; 2013 Feb; 74(2):170-9. PubMed ID: 23473350
[TBL] [Abstract][Full Text] [Related]
15. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
[TBL] [Abstract][Full Text] [Related]
16. Lurasidone : in the treatment of schizophrenia.
Sanford M
CNS Drugs; 2013 Jan; 27(1):67-80. PubMed ID: 23264146
[TBL] [Abstract][Full Text] [Related]
17. The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.
Tarazi FI; Riva MA
Expert Opin Drug Discov; 2013 Oct; 8(10):1297-307. PubMed ID: 23837554
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.
Stahl SM; Cucchiaro J; Simonelli D; Hsu J; Pikalov A; Loebel A
J Clin Psychiatry; 2013 May; 74(5):507-15. PubMed ID: 23541189
[TBL] [Abstract][Full Text] [Related]
19. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
[TBL] [Abstract][Full Text] [Related]
20. Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension.
Harvey PD; Siu CO; Hsu J; Cucchiaro J; Maruff P; Loebel A
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1373-82. PubMed ID: 24035633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]